We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), société de biopharmaceutique au stade clinique spécialisée dans le développement de médicaments innovants pour le traitement des urgences...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: This replaces the announcement made at 17:45 on October 31 because the following statement has been deleted: “The limited review procedures for the interim financial statements...
Repositionnement du glenzocimab dans le traitement de l’infarctus du myocarde avec élévation du segment ST (STEMI) Procédure de redressement judiciaire : prorogation de l'appel d'offres en vue...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.25 | 0.25 | 0.25 | 0 | 0 | DE |
4 | -0.036 | -12.5874125874 | 0.286 | 0.3 | 0.23 | 4090 | 0.26564774 | DE |
12 | -0.286 | -53.3582089552 | 0.536 | 0.89 | 0.23 | 49213 | 0.55976704 | DE |
26 | -0.46 | -64.7887323944 | 0.71 | 0.89 | 0.22 | 31676 | 0.51255747 | DE |
52 | -2.7 | -91.5254237288 | 2.95 | 5.32 | 0.22 | 52377 | 1.0025583 | DE |
156 | -4.35 | -94.5652173913 | 4.6 | 11 | 0.22 | 18951 | 1.57024431 | DE |
260 | 0.098 | 64.4736842105 | 0.152 | 11 | 0.14 | 59242 | 1.25488098 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions